Patents by Inventor Jose Escaich

Jose Escaich has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HEPARIN AND MIXTURES OF NATIVE PROTEINS AND PEPTIDES FROM WASTE TISSUE OF SLAUGHTERED ANIMALS
    Publication number: 20250101140
    Abstract: A method for obtaining heparin, proteins and peptides in native state, and other compounds of interest, by fractionation of mammalian intestine mucosa. Particular new fractions or extracts of the mucosa with the indicated compounds are also contemplated.
    Type: Application
    Filed: March 7, 2023
    Publication date: March 27, 2025
    Inventors: JOSÉ ESCAICH FERRER, PABLO RAMIREZ RUBIO, STEFANO CARLINO, CARLOS CHETRIT RUSSO, PAU SALVATELLA SUREDA, PILAR DALMAU PUIG, JUDITH PUIGSEGUR SARABIA, MARC MONTERO PARDILLO
  • Compositions for the skin
    Patent number: 11077136
    Abstract: The present invention relates to a composition comprising hyaluronic acid, dermatan sulfate, at least one omega-3 fatty acid, and at least one nucleotide. It also relates to the new composition for use in the treatment or prevention of diseases, ailments, dysfunctions, or alterations of the skin, preferably atopic dermatitis. The composition may be in the form of a pharmaceutical composition, food supplement, functional food, or medical food.
    Type: Grant
    Filed: April 12, 2017
    Date of Patent: August 3, 2021
    Assignee: BIOIBERICA, S.A.U.
    Inventors: José Escaich Ferrer, Sergi Segarra López, Javier Córdoba Lucio, Jorge Flores García, Alfonso Velasco Franco
  • COMPOSITIONS FOR THE SKIN
    Publication number: 20190192553
    Abstract: The present invention relates to a composition comprising hyaluronic acid, dermatan sulfate, at least one omega-3 fatty acid, and at least one nucleotide. It also relates to the new composition for use in the treatment or prevention of diseases, ailments, dysfunctions, or alterations of the skin, preferably atopic dermatitis. The composition may be in the form of a pharmaceutical composition, food supplement, functional food, or medical food.
    Type: Application
    Filed: April 12, 2017
    Publication date: June 27, 2019
    Applicant: BIOIBERICA, S.A.U.
    Inventors: José ESCAICH FERRER, Sergi SEGARRA LÓPEZ, Javier CÓRDOBA LUCIO, Jorge FLORES GARCÍA, Alfonso VELASCO FRANCO
  • MARKERS FOR JOINT DISPLASIA, OSTEOARTHRITIS AND CONDITIONS SECONDARY THERETO
    Publication number: 20130263294
    Abstract: A method for predicting risk of joint dysplasia, osteoarthritis and/or a condition that is secondary to joint dysplasia in a mammalian subject of the order Carnivora, the method comprising: (a) determining the genotype of said subject in respect of one or more genetic polymorphisms and/or alterations, such as polymorphisms in the CHST3 gene; and (b) providing a prediction of said risk based on said genotype. Products for use in such a method and related methods of determining propensity of a subject to respond to therapy and of selective breeding, are also disclosed.
    Type: Application
    Filed: September 19, 2011
    Publication date: October 3, 2013
    Applicants: BIOIBERICA, S.A., PROGENIKA BIOPHARMA, S.A.
    Inventors: Antonio Martinez, Laureano Simon, Diego Tejedor, Marta Artieda, Nerea Bartolome, Jose Escaich, Alfonso Velasco, Miriam Selles, Carlos Chetrit, Daniel Martinez, Armand Sanchez, Olga Francino, Elisenda Sanchez